Frank Dolan

Noma Therapy Secures $4.25M for Pioneering Virtual Ketamine-Assisted Mental Health Solutions

Noma Therapy Secures $4.25M for Pioneering Virtual Ketamine-Assisted Mental Health Solutions

Frank Dolan April 30, 2025

Is Liquidation the Best Move for Acelyrin? How Shareholder Pressure is Shifting Biotech Strategies!

Is Liquidation the Best Move for Acelyrin? How Shareholder Pressure is Shifting Biotech Strategies!

Frank Dolan April 30, 2025

Join the Conversation: Endpoints News Launches 'Post-Hoc Live!' to Explore Pharma's 'Liberation Day' Response

Join the Conversation: Endpoints News Launches ‘Post-Hoc Live!’ to Explore Pharma’s ‘Liberation Day’ Response

Frank Dolan April 29, 2025

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

Frank Dolan April 29, 2025

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Frank Dolan April 29, 2025

Vaxart's Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Vaxart’s Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Frank Dolan April 28, 2025

Keytruda's Breakthrough: New Hope in Head and Neck Cancer Surgery with Pre- and Post-Operative Use

Keytruda’s Breakthrough: New Hope in Head and Neck Cancer Surgery with Pre- and Post-Operative Use

Frank Dolan April 28, 2025

Promising Breakthrough: Johnson & Johnson’s 'Pretzel' Drug Shows 45% Success in Bladder Cancer Treatment!

Promising Breakthrough: Johnson & Johnson’s ‘Pretzel’ Drug Shows 45% Success in Bladder Cancer Treatment!

Frank Dolan April 27, 2025

Key Earnings Insights: Pharma Giants Navigate Tariff Pressures, Akeso's Promising Data, and a CRISPR Breakthrough

Key Earnings Insights: Pharma Giants Navigate Tariff Pressures, Akeso’s Promising Data, and a CRISPR Breakthrough

Frank Dolan April 26, 2025

Biohaven Pharmaceuticals Faces $400 Million Stock Plunge After Dazluma Marketing Setback: What's Next?

Biohaven Pharmaceuticals Faces $400 Million Stock Plunge After Dazluma Marketing Setback: What’s Next?

Frank Dolan April 26, 2025

Amgen Invests $900 Million to Boost Biomanufacturing in Ohio: A Response to U.S. Pharma Trends

Amgen Invests $900 Million to Boost Biomanufacturing in Ohio: A Response to U.S. Pharma Trends

Frank Dolan April 25, 2025

Gilead Sciences' HIV Drug Sales Surge in Q1 2025 Amidst Challenges in Covid-19 and Cancer Markets

Gilead Sciences’ HIV Drug Sales Surge in Q1 2025 Amidst Challenges in Covid-19 and Cancer Markets

Frank Dolan April 25, 2025

Bristol Myers Squibb's Cobenfy: A Game Changer for Schizophrenia Treatment with $27 Million Launch Success!

Bristol Myers Squibb’s Cobenfy: A Game Changer for Schizophrenia Treatment with $27 Million Launch Success!

Frank Dolan April 25, 2025

How Trump's Tariffs Are Shaping the Future of the Pharmaceutical Industry: Insights from Major Players

How Trump’s Tariffs Are Shaping the Future of the Pharmaceutical Industry: Insights from Major Players

Frank Dolan April 24, 2025

AstraZeneca's CEO Urges Europe to Boost Investment in Drug R&D for Health Sovereignty

AstraZeneca’s CEO Urges Europe to Boost Investment in Drug R&D for Health Sovereignty

Frank Dolan April 24, 2025

Veraxa Biotech Set to Go Public with $1.6 Billion SPAC Merger: A Game Changer in Cancer Therapy!

Veraxa Biotech Set to Go Public with $1.6 Billion SPAC Merger: A Game Changer in Cancer Therapy!

Frank Dolan April 24, 2025

Big Pharma's Lobbying Surge: How Pfizer, Novartis & Others Tackle New Regulatory Challenges in 2025

Big Pharma’s Lobbying Surge: How Pfizer, Novartis & Others Tackle New Regulatory Challenges in 2025

Frank Dolan April 23, 2025

Eli Lilly Battles Telehealth Firms: Legal Action Against Compounded Tirzepatide Sales

Eli Lilly Battles Telehealth Firms: Legal Action Against Compounded Tirzepatide Sales

Frank Dolan April 23, 2025

Roche's $50 Billion Bet: Transforming U.S. Drug Manufacturing and Creating 12,000 Jobs

Roche’s $50 Billion Bet: Transforming U.S. Drug Manufacturing and Creating 12,000 Jobs

Frank Dolan April 23, 2025

FDA Acknowledges Trump-Era Staff Cuts Delaying Drug Approval Decisions: What It Means for Patients and Pharmaceutical Companies

FDA Acknowledges Trump-Era Staff Cuts Delaying Drug Approval Decisions: What It Means for Patients and Pharmaceutical Companies

Frank Dolan April 22, 2025

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA